High albumin-corrected anion gap linked to increased MACE risk in CKD patients after PCI
Study links higher blood gap measure to more heart problems in kidney disease patients
A retrospective cohort study of 973 chronic kidney disease patients undergoing percutaneous coronary intervention found that a high albumin-…
Higher levels of a specific blood marker found in kidney disease patients are linked to more heart attacks, strokes, and heart-related death…
TRACK trial to assess low-dose rivaroxaban for MACE in advanced CKD/dialysis patients
Can a low-dose blood thinner protect people with advanced kidney disease from heart attacks and strokes?
The TRACK trial is a global, quadruple-blind, placebo-controlled phase 3 study evaluating low-dose rivaroxaban (2.5 mg) for reducing major a…
A new global study tested whether a low-dose blood thinner safely protects people with advanced kidney disease from heart attacks and stroke…